<DOC>
	<DOCNO>NCT00506844</DOCNO>
	<brief_summary>This study estimate pathologic complete response rate cetuximab , irinotecan , capecitabine concurrent radiotherapy give preoperatively patient resectable rectal cancer .</brief_summary>
	<brief_title>Preoperative Chemoradiotherapy With Cetuximab Rectal Cancer</brief_title>
	<detailed_description>Daily fraction radiotherapy 1.8 Gy total 45 Gy tumor drain lymph node follow coned-down boost 5.4 Gy tumor deliver concurrently chemotherapy . Cetuximab 400 mg/m2 give intravenously D-6 ( 1 week radiation ) , follow 250 mg/m2 week ( D 1 , 8 , 15 , 22 &amp; 29 ) . Administration irinotecan capecitabine start day 1 radiotherapy . Capecitabine administer orally dose 825 mg/m2 twice daily weekday ( Monday Friday ) radiotherapy . Irinotecan 40 mg/m2 give intravenously week ( D 1 , 8 , 15 , 22 &amp; 29 ) . Four eight week completion chemoradiotherapy , curative surgery perform . Safety evaluation study perform first 6 patient treat . If 1 6 patient receive less 70-80 % plan dose capecitabine irinotecan , dosage chemotherapy study patient adjust protocol amendment .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Histologically confirm adenocarcinoma rectum Distal margin tumor locate 0 8 cm anal verge Stage T3/T4 ± N+ MRI ± endorectal ultrasonography ECOG performance status 02 No prior chemotherapy , radiotherapy pelvis , immunotherapy , EGFR pathway target therapy Adequate organ function Patients must sign informed consent Malignant disease rectum adenocarcinoma arise chronic inflammatory bowel disease Any define hereditary colorectal cancer Any unresected synchronous colon cancer R0 resection tumor clinically possible Any distant metastasis Intestinal obstruction impend obstruction , decompress colostomy permit Any previous concurrent malignancy nonmelanoma skin cancer situ cancer uterine cervix Any morbidity situation contraindication chemoradiotherapy Patients history significant gastric small bowel resection , malabsorption syndrome , lack integrity upper gastrointestinal tract may compromise absorption capecitabine History severe pulmonary disease Pregnant lactate woman patient childbearing potential predicting adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Rectal neoplasm</keyword>
	<keyword>Neoadjuvant treatment</keyword>
	<keyword>Cetuximab</keyword>
	<keyword>Irinotecan</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Combination chemotherapy</keyword>
</DOC>